Biomedicines Webinar | The Role of Extracellular Vesicles in Pathogenesis and Therapeutic Strategies
Meet Our Speakers
Laboratory for Medical Mass Spectrometry, Biomedicine group, Alborg University, Aalborg, Denmark;
Dr. Allan Stensballe heads the Precision medicine part of the Translational Biomarkers for Pain and Precision Medicine research group at Aalborg University in Denmark. Dr. Stensballe have strong background in protein chemistry and applied proteomics for the study of human disease pathology. In recent years the clinical research focuses on applied omics for investigating triggers of autoimmune diseases and inflammatory mechanisms as well as precision medicine in this context. The research group focus aims to unravel the molecular mechanisms of multiple autoimmune related disorders by application of proteomics approaches also to detect potential biomarkers for patient subtyping as well as predicting treatment outcomes.
On Wednesday 31st January 2023, MDPI and the Journal Biomedicines organized the 4th Webinar on Biomedicines entitled “ The Role of Extracellular Vesicles in Pathogenesis and Therapeutic Strategies”. This online seminar was chaired by Dr. Allan Stensballe from the Laboratory for Medical Mass Spectrometry, Biomedicine group, Alborg University, Aalborg, Denmark. He was joined by two leading experts in extracellular vesicles and their role in therapeutic strategies.
Their presentations detailed how extracellular vesicles can be used in therapeutic strategies for certain diseases such as Malaria. The presentations were followed by a Q&A and a discussion, moderated by the Chair. The webinar was offered via Zoom and required registration to attend. The full recording can be found here on Sciforum website. In order to stay updated on the next webinars on Biomedicines be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.
The Role of Extracellular Vesicles in Pathogenesis and Therapeutic Strategies 2.0
Guest Editor: Dr. Allan Stensballe
Deadline for manuscript submissions: 31 January 2023